Osteogenesis imperfect: clinical and epidemiological findings in a series of pediatric patients

被引:0
作者
Cammarata-Scalisi, Francisco [1 ]
Ramos-Urrea, Carlos [2 ]
Da Silva, Gloria [1 ]
机构
[1] Univ Los Andes, Dept Puericultura & Pediat, Unidad Genet Med, Merida, Venezuela
[2] Univ Fed Sao Paulo, Dept Fisiol Nutr, Sao Paulo, Brazil
来源
BOLETIN MEDICO DEL HOSPITAL INFANTIL DE MEXICO | 2019年 / 76卷 / 06期
关键词
Osteogenesis imperfecta; Type I collagen; Clinical study; Epidemiology; Sillence classification; DIAGNOSIS; CHILDREN; THERAPY;
D O I
10.24875/BMHIM.19000030
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background: Osteogenesis imperfecta (OI) is the most common hereditary bone disorder with an incidence of one in 10,000-25,000 births. It is caused mainly by mutations in the genes that code for Type I collagen chains. In most cases, it shows an autosomal dominant inheritance pattern. OI is characterized by an increase in bone fragility that leads to frequent fractures, which cause pain, deformity and disability associated with other alterations. The objective of this study was to present the clinical and epidemiological characteristics of a series of pediatric patients diagnosed with OI evaluated at the University of Los Andes. Methods: A series of 37 pediatric cases with diagnosis of OI according to the clinical and radiological classification of sillence is analyzed, which were evaluated in the medical genetics unit of the University of Los Andes consultation between January 2006 and December 2018. Results: Type I was the most frequent OI type, with 31 patients (83.78%). Additionally, the femur was the most affected bone. Blue scleras were the most frequent additional finding in 32 patients (86.49%). Conclusions: OI represents the main reason for consultation of alterations in the skeletal system in the medical genetics unit of the University of Los Andes. Given the broad clinical presentation, the evaluation must be individual and interdisciplinary. Further study will provide timely family genetic counseling.
引用
收藏
页码:259 / 264
页数:6
相关论文
共 18 条
  • [1] Long-Term Bisphosphonate Therapy in Osteogenesis Imperfecta
    Biggin, A.
    Munns, C. F.
    [J]. CURRENT OSTEOPOROSIS REPORTS, 2017, 15 (05): : 412 - 418
  • [2] Osteogenesis Imperfecta: Diagnosis and Treatment
    Biggin, A.
    Munns, C. F.
    [J]. CURRENT OSTEOPOROSIS REPORTS, 2014, 12 (03) : 279 - 288
  • [3] Nosology and Classification of Genetic Skeletal Disorders: 2015 Revision
    Bonafe, Luisa
    Cormier-Daire, Valerie
    Hall, Christine
    Lachman, Ralph
    Mortier, Geert
    Mundlos, Stefan
    Nishimura, Gen
    Sangiorgi, Luca
    Savarirayan, Ravi
    Sillence, David
    Spranger, Juergen
    Superti-Furga, Andrea
    Warman, Matthew
    Unger, Sheila
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2015, 167 (12) : 2869 - 2892
  • [4] Abnormal Type I Collagen Post-translational Modification and Crosslinking in a Cyclophilin B KO Mouse Model of Recessive Osteogenesis Imperfecta
    Cabral, Wayne A.
    Perdivara, Irina
    Weis, MaryAnn
    Terajima, Masahiko
    Blissett, Angela R.
    Chang, Weizhong
    Perosky, Joseph E.
    Makareeva, Elena N.
    Mertz, Edward L.
    Leikin, Sergey
    Tomer, Kenneth B.
    Kozloff, Kenneth M.
    Eyre, David R.
    Yamauchi, Mitsuo
    Marini, Joan C.
    [J]. PLOS GENETICS, 2014, 10 (06):
  • [5] Molecular spectrum and differential diagnosis in patients referred with sporadic or autosomal recessive osteogenesis imperfecta
    Caparros-Martin, Jose A.
    Aglan, Mona S.
    Temtamy, Samia
    Otaify, Ghada A.
    Valencia, Maria
    Nevado, Julian
    Vallespin, Elena
    Del Pozo, Angela
    Prior de Castro, Carmen
    Calatrava-Ferreras, Lucia
    Gutierrez, Pilar
    Bueno, Ana M.
    Sagastizabal, Belen
    Guillen-Navarro, Encarna
    Ballesta-Martinez, Maria
    Gonzalez, Vanesa
    Basaran, Sarenur Y.
    Buyukoglan, Ruksan
    Sarikepe, Bilge
    Espinoza-Valdez, Cecilia
    Cammarata-Scalisi, Francisco
    Martinez-Glez, Victor
    Heath, Karen E.
    Lapunzina, Pablo
    Ruiz-Perez, Victor L.
    [J]. MOLECULAR GENETICS & GENOMIC MEDICINE, 2017, 5 (01): : 28 - 39
  • [6] Escribano-Rey R J, 2014, Rev Esp Cir Ortop Traumatol, V58, P114, DOI 10.1016/j.recot.2013.11.007
  • [7] A comparative study of quality of life, functional and bone outcomes in osteogenesis imperfecta with bisphosphonate therapy initiated in childhood or adulthood
    Feehan, Andrew G.
    Zacharin, Margaret R.
    Lim, Angelina S.
    Simm, Peter J.
    [J]. BONE, 2018, 113 : 137 - 143
  • [8] Osteogenesis imperfecta
    Forlino, Antonella
    Marini, Joan C.
    [J]. LANCET, 2016, 387 (10028) : 1657 - 1671
  • [9] Update on the Evaluation and Treatment of Osteogenesis Imperfecta
    Harrington, Jennifer
    Sochett, Etienne
    Howard, Andrew
    [J]. PEDIATRIC CLINICS OF NORTH AMERICA, 2014, 61 (06) : 1243 - +
  • [10] Hoyer-Kuhn H, 2015, WIEN MED WOCHENSCHR, V165, P278, DOI 10.1007/s10354-015-0361-x